Gynecologic Oncology

This month's collection of trials in progress highlights trials presented at the 2011 American Society of Clinical Oncology Meeting.

New findings demonstrate a recent increase in the annual completion rates of vaccination against human papillomavirus (HPV) infection.

Dr. Teresa Woodruff from Feinberg School of Medicine, Northwestern University, Discusses Oncofertility Insurance Coverage

Dr. Gordon Mills from MD Anderson Cancer Center Gives Examples of Unexpected Therapy Responses

This month's collection of trials in progress highlights trials presented at the 2011 American Society of Clinical Meeting.

This report highlights 5 abstracts relevant to the current and future management of patients with female pelvic malignancies.

Temporary ovarian suppression using triptorelin may decrease the rate of early menopause in premenopausal women with early-stage breast cancer undergoing adjuvant or neoadjuvant chemotherapy.

British investigators are reporting that taller women have a higher risk of cancer, and that the link between height and cancer risk exists for most types of cancer.

Now more than ever, oncology nurses need to be able to fill the knowledge gap and accurately educate their patients and the public about cancer screening tests and their frequency.

Postmenopausal women at risk of breast cancer got good news from the MAP.3 trial results: Exemestane reduced their risk of invasive breast cancer by 65% compared with placebo.

A novel topoisomerase-I inhibitor designated NKTR-102 demonstrated clinically significant activity as a single agent in patients with heavily pretreated ovarian cancer who failed prior PLD.

It had been thought that removing the sentinel node and the surrounding lymph nodes would improve survival rates.

Dr. Debu Tripathy from USC Norris Comprehensive Cancer Center on Breast Cancer with Bone Metastases

New data suggest that, contrary to expectation, the use of supplements containing one-carbon nutrients like folate and vitamins B2, B6, and B12 appears to be associated with an increased risk of type II endometrial cancer.

Older women with estrogen receptor (ER)-negative metastatic breast cancer have a 39% lower risk of all-cause mortality if they receive chemotherapy within 6 months of their diagnosis.

Clinical observations are more effective than routine testing in posttreatment surveillance and diagnosis of most gynecologic tumors

Long-term use of talc-based powder significantly increased the risk of invasive ovarian cancer in a large case-control study

While cervical cancer is a rare disease of women within the United States, it remains a global medical problem

A large-scale study of HPV testing and Pap smear for cervical cancer screening confirms that women can safely extend screening intervals from 1 to 3 years.

Dr. Markman on HPV Testing to Detect Cervical Cancer

Dr. Pecora on HPV Cervical Cancer Findings

Dr. Markman Discusses the Olaparib Phase II Trial

Dr. Markman Discusses the Importance of Cancer Screening

Fiona McCaughan on Nurses Facilitating Intraperitoneal Chemotherapy Completion

Investigators have reported an increased risk of invasive breast cancer in postmenopausal women who are or were cigarette smokers